Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry

Chinese Journal of Lung Cancer

Volumn 14, Issue 12, 2011, Pages 918-925

  Wu, Shiwu ^a   Cheng, Zenong ^a   Yu, Lan ^a   Song, Wenqing ^a   Tao, Yisheng ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

CD82 KAI1; HIF 1 ; Lung neoplasms; Prognosis; Vasculogenic mimicry

Indexed keywords

CD82 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULATURE; PREDICTION; PROGNOSIS; SURVIVAL TIME; VASCULOGENIC MIMICRY;

ADULT; AGED; ANTIGENS, CD82; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE;

EID: 83455217829     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.12.04     Document Type: Article

References (22)

1. Muneyuki T, Watanabe M, Yamanaka M, et al. KAI1/CD82 expression as a prognostic factor in sporadic colorectal cancer. Anticancer Res, 2001, 21(2): 3581-3587.
2. Gellersen B, Briese J, Oberndörfer M, et al. Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications. Am J Pathol, 2007, 170(1): 126-139.
3. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem, 2005, 53(8): 997-1002.
4. Kumada T, Tsuneyama K, Hatta H, et al. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol, 2004, 17(9): 1141-1149.
5. Vartanian A, Baryshnikov AY. Crosstalk between apoptosis and antioxidants in melanoma vasculogenic mimicry. Adv Exp Med Biol, 2007, 601(4): 145-153.
6. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS, 2004, 112(7-8): 508-525.
7. Zhao XL, Du J, Zhang SW, et al. A study on vasculogenic mimicry in hepatocellular carcinoma. Chin J Hepatol, 2006, 14(1): 41-44.
8. Sood AK, Seftor EA, Fletcher MS, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol, 2001, 158(4): 1279-1288.
9. Danny R, Gray I, Wendy J, et al. Short-term human prostate primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis. Cancer Res, 2004, 64(3): 1712-1721.
10. Sun BC, Zhang SW, Ni CS, et al. The clinical significance study of vasculogenetic mimicry in 337 cases of Bi-directional differential malignant tumors. Chin J Clin Oncol, 2005, 32(2): 64-67.
11. Swinson DE, Jones JL, Cox G, et al. Hypoxia-inducible factor-1 alpha in non small cell lung cancer: elation to growth factor, protease and apoptosis pathways. Int J Cancer, 2004, 111(1): 43-50.
12. Liu LX, Lu H, Luo Y, et al. Stabilization of vascular endothelial growth fac tor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun, 2002, 291(4): 908-914.
13. Sun B, Zhang D, Zhang S, et al. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett, 2007, 249(2): 188-197.
14. Li M, Gu Y, Zhang Z, et al. Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res, 2010, 16(2): 259-266.
15. Yao LQ, Feng YJ, Ding JX, et al. Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma. Zhonghua Fuchanke Zazhi, 2005, 4(10): 662-665.
16. Hendrix MJ, Seftor RE, Seftor EA, et al. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res, 2002, 62(3): 665-668.
17. Dong JT, Lamb PW, Rinker Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11P11.2. Science, 1995, 268(5212): 884-886.
18. Takeda TY, Hattori N, Tokuhara T. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res, 2007, 67(5): 1744-1749.
19. Zheng HC, Tsuneyama K, Cheng C, et al. Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma. J Clin Pathol, 2007, 609(11): 50-56.
20. Xu XJ, Mei TH. Expression of KAI1 in non-small cell lung cancer and its relationship between to metastasis and prognosis. Mod Pract Med, 2010, 22(2): 190-192.
21. Shirakawa K, Wakasugi H, Heike Y, et al. Vasculogenic mimicry and pseudocomedo formation in breast cancer. Int J Cancer, 2002, 99(6): 821-828.
22. Bos R, Vander Groep P, Greijer AE, et al. Levels of hypoxia-inducible factor- 1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer, 2003, 97(6): 1573-1581.